{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:16:18Z","timestamp":1759482978664},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00063-010-1037-3","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T00:58:28Z","timestamp":1273280308000},"page":"262-266","source":"Crossref","is-referenced-by-count":5,"title":["Allopurinolinduziertes Hypersensitivit\u00e4tssyndrom mit Todesfolge"],"prefix":"10.1007","volume":"105","author":[{"given":"S\u00f6ren","family":"Laurisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Jaedtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reyhan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajoscha A.","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan T.","family":"Kielstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Oliver","family":"Rennekampff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd P.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"Drexler \u2020","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Schieffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Christian","family":"Napp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,9]]},"reference":[{"key":"1037_CR1","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/1097-0142(196005\/06)13:3<482::AID-CNCR2820130310>3.0.CO;2-S","volume":"13","author":"R.K. Shawk","year":"1960","unstructured":"Shawk RK, Shukman RN, Davidson JK, et al. Studies with the experimental antitumor agent 4-amino pyrazolo (3,4-d) pyrimidine. Cancer 1960;13:482\u20139.","journal-title":"Cancer"},{"key":"1037_CR2","first-page":"2158","volume-title":"Harrison's principles of internal medicine","author":"R.L. Wortmann","year":"1998","unstructured":"Wortmann RL. Gout and other disorders of purine metabolism. In: Fauci AS, Braunwald E, Isselbacher KJ, et al, eds. Harrison's principles of internal medicine, 14th edn. New York: McGraw-Hill, 1998:2158\u201365.","edition":"14th edn."},{"key":"1037_CR3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00002281-200205000-00015","volume":"14","author":"R.L. Wortmann","year":"2002","unstructured":"Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol 2002;14:281\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"1037_CR4","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","volume":"349","author":"R.A. Terkeltaub","year":"2003","unstructured":"Terkeltaub RA. Clinical practice: gout. N Engl J Med 2003;349:1647\u201355.","journal-title":"N Engl J Med"},{"key":"1037_CR5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.332.7553.1315","volume":"332","author":"M. Underwood","year":"2006","unstructured":"Underwood M. Diagnosis and management of gout. BMJ 2006;332:1315\u20139.","journal-title":"BMJ"},{"key":"1037_CR6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0300-2977(97)00088-0","volume":"52","author":"H.J. Pluim","year":"1998","unstructured":"Pluim HJ, van Deuren M, Wetzels JF. The allopurinol hypersensitivity syndrome. Neth J Med 1998;52:107\u201310.","journal-title":"Neth J Med"},{"key":"1037_CR7","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S. Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol 2008;58:25\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"1037_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/art.1780290111","volume":"29","author":"J.Z. Singer","year":"1986","unstructured":"Singer JZ, Wallace SL. The allopurinol hypersensitivity syndrome: unnecessary morbidity and mortality. Arthritis Rheum 1986;29:82\u20137.","journal-title":"Arthritis Rheum"},{"key":"1037_CR9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","volume":"2006","author":"S. Tas","year":"2003","unstructured":"Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;2006:353\u20136.","journal-title":"Dermatology"},{"key":"1037_CR10","first-page":"357","volume":"137","author":"J.R. Sullivan","year":"2001","unstructured":"Sullivan JR, Shear NH. The drug hypersensitivity syndrome: what is the pathogenesis? Arch Dermatol 2001;137:357\u201364.","journal-title":"Arch Dermatol"},{"key":"1037_CR11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/archderm.134.7.874","volume":"134","author":"R.D. Sontheimer","year":"1998","unstructured":"Sontheimer RD, Houpt KR. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol 1998;134:874\u20136.","journal-title":"Arch Dermatol"},{"key":"1037_CR12","first-page":"60","volume":"1","author":"B.E. Anderson","year":"2002","unstructured":"Anderson BE, Adams DR. Allopurinol hypersensitivity syndrome. J Drugs Dermatol 2002;1:60\u20132.","journal-title":"J Drugs Dermatol"},{"key":"1037_CR13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/106002809302700317","volume":"27","author":"F. Arellano","year":"1993","unstructured":"Arellano F, Sacrist\u00e1n JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993;27:337\u201343.","journal-title":"Ann Pharmacother"},{"key":"1037_CR14","first-page":"656","volume":"7","author":"A. Markel","year":"2005","unstructured":"Markel A. Allopurinol-induced DRESS syndrome. Isr Med Assoc J 2005;7:656\u201360.","journal-title":"Isr Med Assoc J"},{"key":"1037_CR15","first-page":"384","volume":"49","author":"H.Y. Lee","year":"2008","unstructured":"Lee HY, Ariyasinghe JTN, Thirumoorthy T. Allopurinol hypersensitivity syndrome: a preventable severe cutaneous adverse reaction? Singapore Med J 2008;49:384\u20137.","journal-title":"Singapore Med J"},{"key":"1037_CR16","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"S.I. Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005;102:4134\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1037_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00130832-200308000-00004","volume":"3","author":"K. Hashimoto","year":"2003","unstructured":"Hashimoto K, Yasukawa M, Tohyama M. Human herpesvirus 6 and drug allergy. Curr Opin Allergy Clin Immunol 2003;3:255\u201360.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"1037_CR18","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","volume":"353","author":"M.A. Becker","year":"2005","unstructured":"Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450\u201361.","journal-title":"N Engl J Med"},{"key":"1037_CR19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jbspin.2004.07.006","volume":"71","author":"T. Bardin","year":"2004","unstructured":"Bardin T. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 2004;71:481\u20135.","journal-title":"Joint Bone Spine"},{"key":"1037_CR20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.rhu.0000164822.98163.22","volume":"11","author":"F. Perez-Ruiz","year":"2005","unstructured":"Perez-Ruiz F, Hernando I, Villar I, Nolla JM. Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels:another insight to allopurinol-related toxicity. J Clin Rheumatol 2005;11:129\u201333.","journal-title":"J Clin Rheumatol"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1037-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00063-010-1037-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-010-1037-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:13:25Z","timestamp":1558563205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00063-010-1037-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["1037"],"URL":"https:\/\/doi.org\/10.1007\/s00063-010-1037-3","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}